GLP-1 weight loss claims on TikTok: what the data says

What did @therealslim_shelby actually say?

Nothing about GLP-1 medications, weight loss, or health of any kind. The transcript is entirely song lyrics, specifically what appears to be a rendition of "Get Silly" by V.I.C. There are no medical claims, anecdotes, or health-adjacent statements in this video whatsoever.

The full transcript reads: "Dance flow silly, the ladies gon' film it, the fellas in the bag, and they twistin' up a thillie. Get silly, get silly..." and repeats from there. This is a dance or lip-sync video that was tagged under the GLP-1 category, but the content itself has no connection to semaglutide, tirzepatide, liraglutide, or any other GLP-1 receptor agonist.

It is possible the creator uses the GLP-1 tag to reach a specific community or boost discoverability, a common tactic on TikTok that has nothing to do with the content itself. Either way, there is nothing here to fact-check on medical grounds.

Does the science back this up?

There is no scientific claim in this video to evaluate. The creator made zero assertions about drug efficacy, weight loss outcomes, side effects, dosing, or metabolic health. Assigning a scientific verdict to song lyrics would be absurd.

That said, since this video was categorized under GLP-1 content and may reach people actively researching these medications, it is worth noting the general evidentiary landscape for GLP-1 drugs is strong. The SUSTAIN trial series (Marso et al., 2016, New England Journal of Medicine) established cardiovascular and glycemic benefits for semaglutide. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) demonstrated that tirzepatide produced average body weight reductions of up to 22.5% in adults with obesity. These are real findings. They are just entirely unrelated to this video.

What did they get wrong (or right)?

The creator got nothing wrong medically because they said nothing medical. They also got nothing right in a clinical sense. This is a non-event from a fact-check standpoint.

What is worth flagging is the category tagging. Using health-specific tags like GLP-1 to drive traffic to unrelated content is a known behavior on short-form video platforms. It can dilute information quality for people who are genuinely trying to learn about these medications, many of whom may be newly prescribed patients with real questions about side effects, administration, and expectations. That is not a medical error by this creator, but it is a context problem worth naming plainly.

No misinformation was spread here. No accurate information was shared either. The video is medically inert.

What should you actually know?

If you found this video while researching GLP-1 medications, the content you watched will not help you. Here is what actually matters for anyone on or considering these drugs.

GLP-1 receptor agonists work by mimicking the hormone glucagon-like peptide-1, slowing gastric emptying and reducing appetite signaling in the brain. They are not appetite suppressants in the traditional stimulant sense. They are FDA-approved for type 2 diabetes and, in higher-dose formulations, for chronic weight management. Semaglutide (Wegovy) and tirzepatide (Zepbound) carry the most robust weight loss data currently available for pharmacological obesity treatment.

Common side effects include nausea, vomiting, constipation, and diarrhea, particularly during dose escalation. These are documented extensively in prescribing literature and patient-reported outcomes. If you are experiencing side effects or have questions about your regimen, that conversation belongs with a licensed prescriber, not a TikTok comment section.

• Compounded versions of semaglutide are not equivalent to brand-name Ozempic or Wegovy. FDA guidance is clear on this point.
• Do not adjust your dose based on social media content, including videos tagged GLP-1 that contain no medical information.
• Telehealth platforms operating under regulatory oversight can connect you with licensed providers who will review your full health history before prescribing.